Results Healthcare is delighted to announce that it has advised Lucid, a specialist provider of strategic medical communications services to global pharmaceutical companies, on securing growth equity investment from UK mid-market private equity investor, LDC.
Founded in 2007 by Jan Steele and Dennis O’Brien, who will both continue to lead the business, Lucid Group provides medical education, medical communication, strategic consultancy and digital services to clients to drive better disease and patient management from offices in London, Beaconsfield and NYC.
With growth exceeding 30 per cent for the previous two years and a staff base of over 100 employees, Lucid has built strong, sustainable partnerships with many of the world’s leading Pharma companies.
The investment will enable Lucid to continue to build infrastructure to support this rapid growth, ensuring that its services and offerings remain of the highest quality. It will also enable stronger market presence in the US, where the business launched in 2016. In addition, the investment will support Lucid to build its digital and creative capability, to broaden support for clients.
Results Healthcare advised Lucid throughout the investment process. Lucid CEO Dennis O’Brien:
“Results have been an informal and formal partner to Lucid for years. They have supported us every step of the way and we were delighted with our end result.
“Results brought outstanding industry knowledge and expertise, they pushed us to consider many different approaches and they were as committed as us when it mattered through the process.
“If considering a corporate advisory partner in this sector, I’d say you have to talk to Results.”